\-\ Texto\\:\\ \ \(0\)\
\-\ right\\ facial\\ numbness\\ and\\ slurring\\ of\\ speech\ \(0\)\
\-\ the\\ primary\\ medications\\ used\\ post\\-stroke\\ are\\ aspirin\\,\\ coumadin\\,\\ and\\ clopidogrel\\ for\\ stroke\\ prophylaxis\\.\\ \\ \\ depending\\ on\\ the\\ severity\\ and\\ origin\\ of\\ the\\ stroke\\,\\ carotid\\ endartarectomy\\,\\ angioplasty\\ and\\ intralumenal\\ stents\\,\\ or\\ extracranial\\-intracranial\\ bypass\\ may\\ be\\ considered\\.\ \(0\)\
\-\ mri\\â\\€\\“brain\\:\\ diffusion\\-weighted\\ images\\ \\â\\€\\“\\ increased\\ signal\\ intensity\\ involving\\ l\\ insular\\ cortex\\ and\\ adjacent\\ operculum\\.\\ \\ flair\\ and\\ t2\\-weighted\\ images\\ \\â\\€\\“\\ increased\\ signal\\ intensity\\ throughout\\ l\\ corona\\ radiate\\ w\\/\\ volume\\ loss\\ of\\ the\\ l\\ frontal\\ and\\ parietal\\ lobes\\.\\ \\ large\\ wedge\\-shaped\\ region\\ of\\ encephalomalacia\\ in\\ the\\ lateral\\ r\\ frontal\\ lobe\\ possibly\\ secondary\\ to\\ prior\\ infarct\\.\\ \ \(0\)\
\-\ mra\\-brain\\:\\ severe\\ near\\ occlusion\\ of\\ icas\\ bilaterally\\,\\ normal\\ appearance\\ of\\ vertebral\\ and\\ basilar\\ arteries\\.\\ \\ \ \(0\)\
\-\ dopper\\ u\\/s\\-carotids\\:\\ r\\ ica\\ completely\\ occluded\\ within\\ a\\ centimeter\\ past\\ bifurcation\\,\\ l\\ ica\\ \\â\\€\\“\\ very\\ high\\ resistance\\,\\ abnormal\\ flow\\ at\\ origin\\,\\ possibly\\ due\\ to\\ clot\\ or\\ very\\,\\ very\\ slow\\ flow\\ just\\ above\\ bifurcation\ \(0\)\
\-\ cerebral\\ infarct\\ \\(l\\ mca\\ territory\\)\ \(0\)\
\-\ cerebral\\ infarct\\ \\(l\\ mca\\ territory\\)\\,\\ tia\\,\\ common\\ neurologic\\ deficits\\ after\\ \\(old\\)\\ stroke\ \(0\)\
\-\ 36\\ y\\.o\\.\\ african\\-american\\ female\\ with\\ sickle\\ cell\\ anemia\ \(0\)\
\-\ cerebral\\ infarcts\\ \\(strokes\\)\\ are\\ either\\ ischemic\\ or\\ hemorrhagic\\ in\\ origin\\.\\ \\ ischemia\\ is\\ responsible\\ for\\ two\\-thirds\\ of\\ strokes\\,\\ while\\ hemorrhage\\ causes\\ about\\ one\\-third\\.\\ \\ ct\\ or\\ mri\\ provide\\ a\\ more\\ definitive\\ diagnosis\\ than\\ simply\\ the\\ history\\ or\\ clinical\\ symptoms\\.\\ \\ \ \(0\)\
\-\ \\ \\ \\ ischemic\\ strokes\\ can\\ be\\ caused\\ by\\ thrombosis\\ or\\ embolism\\.\\ \\ thrombosis\\ more\\ commonly\\ occludes\\ larger\\ cerebral\\ arteries\\,\\ such\\ as\\ the\\ icas\\,\\ mca\\ or\\ basilar\\ artery\\,\\ or\\ the\\ venous\\ system\\.\\ \\ these\\ are\\ generally\\ preceded\\ by\\ tias\\,\\ which\\ give\\ warning\\ of\\ an\\ impending\\ stroke\\ and\\ its\\ affected\\ territory\\.\\ \\ the\\ symptoms\\ generally\\ progress\\ over\\ minutes\\ to\\ hours\\.\\ \\ embolism\\ usually\\ occurs\\ when\\ thrombi\\ pass\\ to\\ distal\\ cerebral\\ arteries\\ from\\ larger\\ vessels\\ such\\ as\\ the\\ heart\\,\\ aorta\\,\\ or\\ large\\ cerebral\\ arteries\\.\\ \\ the\\ symptoms\\ at\\ presentation\\ usually\\ do\\ not\\ progress\\ further\\.\\ \\ \\ hemorrhagic\\ strokes\\ can\\ result\\ in\\ destruction\\ or\\ compression\\ of\\ brain\\ tissue\\ or\\ vessels\\ that\\ then\\ cause\\ neurologic\\ symptoms\\.\\ \\ some\\ common\\ causes\\ are\\ intracerebral\\ hemorrhage\\,\\ subarachnoid\\ hemorrhage\\,\\ or\\ subdural\\ or\\ epidural\\ hemorrhage\\.\\ \ \(0\)\
\-\ \\ \\ \\ a\\ patient\\ who\\ suffers\\ from\\ a\\ cerebral\\ infarct\\ often\\ has\\ co\\-morbid\\ conditions\\,\\ broadly\\ broken\\ down\\ into\\ vascular\\,\\ cardiac\\ and\\ hematologic\\ disorders\\.\\ \\ common\\ vascular\\ disorders\\ are\\ atherosclerosis\\,\\ inflammatory\\ disorders\\ \\(e\\.g\\.\\,\\ sle\\,\\ temporal\\ arteritis\\)\\ and\\ migraines\\.\\ \\ arrhythmias\\,\\ endocarditis\\,\\ and\\ rheumatic\\ heart\\ disease\\ can\\ lead\\ to\\ strokes\\.\\ \\ like\\ this\\ patient\\,\\ sickle\\ cell\\ disease\\ and\\ hypercoagulable\\ states\\ can\\ also\\ result\\ in\\ strokes\\.\ \(0\)\
\-\ \\ \\ \\ the\\ middle\\ cerebral\\ artery\\ is\\ the\\ most\\ commonly\\ occluded\\ vessel\\ in\\ an\\ ischemic\\ stroke\\.\\ \\ a\\ stroke\\ of\\ the\\ superior\\ division\\ will\\ result\\ in\\ contralateral\\ hemiparesis\\ affecting\\ the\\ upper\\ body\\ \\(but\\ not\\ the\\ legs\\)\\,\\ contralateral\\ hemisensory\\ deficit\\ and\\ if\\ the\\ dominant\\ hemisphere\\ is\\ involved\\,\\ broca\\â\\€\\™s\\ aphasia\\.\\ \\ an\\ inferior\\ division\\ stroke\\ may\\ result\\ in\\ cortical\\ sensory\\ function\\ impairment\\ such\\ as\\ contralateral\\ graphesthesia\\ and\\ stereognosis\\ and\\ disorders\\ of\\ spatial\\ thought\\.\\ \\ in\\ the\\ dominant\\ hemisphere\\,\\ wernicke\\â\\€\\™s\\ aphasia\\ may\\ occur\\.\\ \\ a\\ stroke\\ at\\ the\\ bifurcation\\ or\\ trifurcation\\ will\\ have\\ superior\\ and\\ inferior\\ divisional\\ symptoms\\,\\ plus\\ homonymous\\ hemianopia\\ and\\ global\\ aphasia\\.\\ \\ finally\\,\\ an\\ occlusion\\ of\\ the\\ stem\\ of\\ the\\ mca\\ will\\ logically\\ be\\ the\\ most\\ devastating\\,\\ as\\ it\\ can\\ cause\\ hemiparesis\\ of\\ the\\ entire\\ contralateral\\ side\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ strokes\\:\\ 0\\.06882107986097344\ \(0\)\
\-\ stroke\\:\\ 0\\.061820583671083625\ \(0\)\
\-\ cerebral\\:\\ 0\\.04104605201752611\ \(0\)\
\-\ l\\:\\ 0\\.040508188888787246\ \(0\)\
\-\ mca\\:\\ 0\\.03442198143678641\ \(0\)\
\-\ contralateral\\:\\ 0\\.03272910822699756\ \(0\)\
\-\ territory\\:\\ 0\\.03000517843800559\ \(0\)\
\-\ disorders\\:\\ 0\\.028340593450635405\ \(0\)\
\-\ aphasia\\:\\ 0\\.027980231643750533\ \(0\)\
\-\ bifurcation\\:\\ 0\\.0270603146169269\ \(0\)\
\-\ infarct\\:\\ 0\\.026285184770330827\ \(0\)\
\-\ icas\\:\\ 0\\.02497774874014696\ \(0\)\
\-\ arteries\\:\\ 0\\.024522729738204373\ \(0\)\
\-\ or\\:\\ 0\\.024300378657698275\ \(0\)\
\-\ result\\:\\ 0\\.02272571339305346\ \(0\)\
\-\ ischemic\\:\\ 0\\.021637217021537133\ \(0\)\
\-\ division\\:\\ 0\\.02116973387474623\ \(0\)\
\-\ origin\\:\\ 0\\.020369212949821077\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.019995000646744355\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.01971754997695692\ \(0\)\
\-\ occluded\\:\\ 0\\.019132345088257084\ \(0\)\
\-\ symptoms\\:\\ 0\\.018454570857002937\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.018436779419410805\ \(0\)\
\-\ ica\\:\\ 0\\.017361719009345505\ \(0\)\
\-\ can\\:\\ 0\\.01679568762971464\ \(0\)\
\-\ progress\\:\\ 0\\.016729755207633357\ \(0\)\
\-\ \\,\\:\\ 0\\.01642088785633459\ \(0\)\
\-\ sickle\\:\\ 0\\.01636455411349878\ \(0\)\
\-\ very\\:\\ 0\\.016127134931319564\ \(0\)\
\-\ basilar\\:\\ 0\\.01554518226578914\ \(0\)\
\-\ post\\-stroke\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ endartarectomy\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ intralumenal\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ extracranial\\-intracranial\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ mri\\â\\€\\“brain\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ mra\\-brain\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ dopper\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ u\\/s\\-carotids\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ co\\-morbid\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ stereognosis\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ divisional\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ devastating\\:\\ 0\\.015278194842229632\ \(0\)\
\-\ possibly\\:\\ 0\\.015157251880333384\ \(0\)\
\-\ dominant\\:\\ 0\\.015116711014603084\ \(0\)\
\-\ hemisphere\\:\\ 0\\.015076638839902649\ \(0\)\
\-\ occlusion\\:\\ 0\\.014771721082724289\ \(0\)\
\-\ embolism\\:\\ 0\\.014491471181063647\ \(0\)\
\-\ larger\\:\\ 0\\.014263563459875499\ \(0\)\
\-\ slurring\\:\\ 0\\.014076899901917768\ \(0\)\
\-\ warning\\:\\ 0\\.014076899901917768\ \(0\)\
\-\ broca\\:\\ 0\\.014076899901917768\ \(0\)\
\-\ graphesthesia\\:\\ 0\\.014076899901917768\ \(0\)\
\-\ logically\\:\\ 0\\.014076899901917768\ \(0\)\
\-\ will\\:\\ 0\\.013900247929180981\ \(0\)\
\-\ such\\:\\ 0\\.013889078630021763\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.013820466851522347\ \(0\)\
\-\ r\\:\\ 0\\.013452493902377145\ \(0\)\
\-\ clopidogrel\\:\\ 0\\.013374187409529269\ \(0\)\
\-\ broadly\\:\\ 0\\.013374187409529269\ \(0\)\
\-\ hemisensory\\:\\ 0\\.013374187409529269\ \(0\)\
\-\ hemianopia\\:\\ 0\\.013374187409529269\ \(0\)\
\-\ generally\\:\\ 0\\.013330000431162902\ \(0\)\
\-\ occludes\\:\\ 0\\.012875604961605905\ \(0\)\
\-\ trifurcation\\:\\ 0\\.012875604961605905\ \(0\)\
\-\ thrombosis\\:\\ 0\\.012714121133979359\ \(0\)\
\-\ operculum\\:\\ 0\\.01248887437007348\ \(0\)\
\-\ impending\\:\\ 0\\.01248887437007348\ \(0\)\
\-\ hematologic\\:\\ 0\\.01248887437007348\ \(0\)\
\-\ wernicke\\:\\ 0\\.01248887437007348\ \(0\)\
\-\ neurologic\\:\\ 0\\.012369131202100562\ \(0\)\
\-\ preceded\\:\\ 0\\.012172892469217404\ \(0\)\
\-\ spatial\\:\\ 0\\.012172892469217404\ \(0\)\
\-\ vessels\\:\\ 0\\.011924575446385902\ \(0\)\
\-\ corona\\:\\ 0\\.011905733578702227\ \(0\)\
\-\ tias\\:\\ 0\\.011905733578702227\ \(0\)\
\-\ migraines\\:\\ 0\\.011905733578702227\ \(0\)\
\-\ arrhythmias\\:\\ 0\\.011674310021294041\ \(0\)\
\-\ rheumatic\\:\\ 0\\.011674310021294041\ \(0\)\
\-\ common\\:\\ 0\\.011627039230275896\ \(0\)\
\-\ causes\\:\\ 0\\.011530609004540074\ \(0\)\
\-\ thrombi\\:\\ 0\\.011470179976828905\ \(0\)\
\-\ homonymous\\:\\ 0\\.011470179976828905\ \(0\)\
\-\ diffusion\\-weighted\\:\\ 0\\.011287579429761616\ \(0\)\
\-\ insular\\:\\ 0\\.011287579429761616\ \(0\)\
\-\ suffers\\:\\ 0\\.011287579429761616\ \(0\)\
\-\ commonly\\:\\ 0\\.011176885419256988\ \(0\)\
\-\ hypercoagulable\\:\\ 0\\.011122397142405767\ \(0\)\
\-\ two\\-thirds\\:\\ 0\\.01097159752890554\ \(0\)\
\-\ radiate\\:\\ 0\\.010832875331897678\ \(0\)\
\-\ encephalomalacia\\:\\ 0\\.010832875331897678\ \(0\)\
\-\ intensity\\:\\ 0\\.010705964216219414\ \(0\)\
\-\ stents\\:\\ 0\\.010584866937373115\ \(0\)\
\-\ one\\-third\\:\\ 0\\.010584866937373115\ \(0\)\
\-\ intracerebral\\:\\ 0\\.010584866937373115\ \(0\)\
\-\ broken\\:\\ 0\\.010584866937373115\ \(0\)\
\-\ e\\.g\\.\\:\\ 0\\.010584866937373115\ \(0\)\
\-\ centimeter\\:\\ 0\\.010473015080982178\ \(0\)\
\-\ tia\\:\\ 0\\.010473015080982178\ \(0\)\
\-\ simply\\:\\ 0\\.010473015080982178\ \(0\)\
\-\ plus\\:\\ 0\\.010473015080982178\ \(0\)\
\-\ heart\\:\\ 0\\.010291437257916028\ \(0\)\
\-\ wedge\\-shaped\\:\\ 0\\.010175181013518298\ \(0\)\
\-\ are\\:\\ 0\\.010094227664901229\ \(0\)\
\-\ give\\:\\ 0\\.010086284489449752\ \(0\)\
\-\ endocarditis\\:\\ 0\\.010086284489449752\ \(0\)\
\-\ inferior\\:\\ 0\\.010049623436253251\ \(0\)\
\-\ cause\\:\\ 0\\.010021707544374233\ \(0\)\
\-\ resistance\\:\\ 0\\.010001726146001862\ \(0\)\
\-\ arteritis\\:\\ 0\\.009844062752231106\ \(0\)\
\-\ global\\:\\ 0\\.009844062752231106\ \(0\)\
\-\ flow\\:\\ 0\\.009788748273339743\ \(0\)\
\-\ may\\:\\ 0\\.00974520815718262\ \(0\)\
\-\ vascular\\:\\ 0\\.009711623112387163\ \(0\)\
\-\ aspirin\\:\\ 0\\.009699553897917325\ \(0\)\
\-\ responsible\\:\\ 0\\.009631580391585815\ \(0\)\
\-\ african\\-american\\:\\ 0\\.009566172544128542\ \(0\)\
\-\ angioplasty\\:\\ 0\\.009503143698078498\ \(0\)\
\-\ superior\\:\\ 0\\.009458383698628045\ \(0\)\
\-\ coumadin\\:\\ 0\\.009383571997061252\ \(0\)\
\-\ atherosclerosis\\:\\ 0\\.009326743881250177\ \(0\)\
\-\ frontal\\:\\ 0\\.00930430479890245\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.009271720140670315\ \(0\)\
\-\ bypass\\:\\ 0\\.009166651472010982\ \(0\)\
\-\ usually\\:\\ 0\\.008994552006470568\ \(0\)\
\-\ finally\\:\\ 0\\.008973886073206434\ \(0\)\
\-\ as\\:\\ 0\\.008960675950739187\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.00885277899357177\ \(0\)\
\-\ sle\\:\\ 0\\.008842194726624246\ \(0\)\
\-\ impairment\\:\\ 0\\.008842194726624246\ \(0\)\
\-\ artery\\:\\ 0\\.008819861324465161\ \(0\)\
\-\ stem\\:\\ 0\\.008800431205689999\ \(0\)\
\-\ clot\\:\\ 0\\.008642767811919243\ \(0\)\
\-\ speech\\:\\ 0\\.00853327231517482\ \(0\)\
\-\ pass\\:\\ 0\\.00853327231517482\ \(0\)\
\-\ s\\:\\ 0\\.008494861931073091\ \(0\)\
\-\ provide\\:\\ 0\\.008301848757766635\ \(0\)\
\-\ affecting\\:\\ 0\\.008241031912339825\ \(0\)\
\-\ an\\:\\ 0\\.008191784154486861\ \(0\)\
\-\ severity\\:\\ 0\\.008043554859741526\ \(0\)\
\-\ slow\\:\\ 0\\.008017094769393539\ \(0\)\
\-\ subdural\\:\\ 0\\.008017094769393539\ \(0\)\
\-\ legs\\:\\ 0\\.008017094769393539\ \(0\)\
\-\ cell\\:\\ 0\\.00800083435556841\ \(0\)\
\-\ infarcts\\:\\ 0\\.007965356531699119\ \(0\)\
\-\ signal\\:\\ 0\\.00780961639609282\ \(0\)\
\-\ depending\\:\\ 0\\.007705494924609145\ \(0\)\
\-\ w\\/\\:\\ 0\\.007683694608826024\ \(0\)\
\-\ minutes\\:\\ 0\\.007662165111428179\ \(0\)\
\-\ sensory\\:\\ 0\\.007662165111428179\ \(0\)\
\-\ deficit\\:\\ 0\\.007640899786312383\ \(0\)\
\-\ \\(\\:\\ 0\\.007511560411547944\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.007498929036801314\ \(0\)\
\-\ 36\\:\\ 0\\.007422736448549813\ \(0\)\
\-\ \\)\\:\\ 0\\.0074198026909529135\ \(0\)\
\-\ more\\:\\ 0\\.00740789015359503\ \(0\)\
\-\ anemia\\:\\ 0\\.007367712707969951\ \(0\)\
\-\ conditions\\:\\ 0\\.007367712707969951\ \(0\)\
\-\ definitive\\:\\ 0\\.007314382277005041\ \(0\)\
\-\ destruction\\:\\ 0\\.007314382277005041\ \(0\)\
\-\ epidural\\:\\ 0\\.007296964017293598\ \(0\)\
\-\ entire\\:\\ 0\\.00727971907647355\ \(0\)\
\-\ increased\\:\\ 0\\.0072460477705360675\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.007195978041342168\ \(0\)\
\-\ numbness\\:\\ 0\\.007116097439608603\ \(0\)\
\-\ completely\\:\\ 0\\.007116097439608603\ \(0\)\
\-\ lead\\:\\ 0\\.007100553817454771\ \(0\)\
\-\ vessel\\:\\ 0\\.007054742280074953\ \(0\)\
\-\ volume\\:\\ 0\\.00699548514879544\ \(0\)\
\-\ states\\:\\ 0\\.006966599442581901\ \(0\)\
\-\ ischemia\\:\\ 0\\.006882723288575228\ \(0\)\
\-\ like\\:\\ 0\\.006855643014913043\ \(0\)\
\-\ be\\:\\ 0\\.006851421438529961\ \(0\)\
\-\ most\\:\\ 0\\.006838250057982932\ \(0\)\
\-\ thought\\:\\ 0\\.006815799829081676\ \(0\)\
\-\ flair\\:\\ 0\\.006789737649940358\ \(0\)\
\-\ deficits\\:\\ 0\\.006776852071972389\ \(0\)\
\-\ carotid\\:\\ 0\\.006641094977917091\ \(0\)\
\-\ medications\\:\\ 0\\.006605844225339755\ \(0\)\
\-\ lobes\\:\\ 0\\.00652627801857359\ \(0\)\
\-\ large\\:\\ 0\\.006476750196988144\ \(0\)\
\-\ either\\:\\ 0\\.0064502048928244985\ \(0\)\
\-\ facial\\:\\ 0\\.006439604846000519\ \(0\)\
\-\ do\\:\\ 0\\.00642906923754925\ \(0\)\
\-\ near\\:\\ 0\\.006408188234921565\ \(0\)\
\-\ affected\\:\\ 0\\.006408188234921565\ \(0\)\
\-\ aorta\\:\\ 0\\.0063570605669896795\ \(0\)\
\-\ down\\:\\ 0\\.0063570605669896795\ \(0\)\
\-\ cortex\\:\\ 0\\.006337024479639461\ \(0\)\
\-\ parietal\\:\\ 0\\.00632709263438992\ \(0\)\
\-\ function\\:\\ 0\\.0062782696240490255\ \(0\)\
\-\ caused\\:\\ 0\\.00621214871249898\ \(0\)\
\-\ involved\\:\\ 0\\.00621214871249898\ \(0\)\
\-\ just\\:\\ 0\\.006184565601050281\ \(0\)\
\-\ occurs\\:\\ 0\\.006078424136161687\ \(0\)\
\-\ at\\:\\ 0\\.006019565785953032\ \(0\)\
\-\ considered\\:\\ 0\\.0059784097208746044\ \(0\)\
\-\ temporal\\:\\ 0\\.005930486789625887\ \(0\)\
\-\ \\:\\:\\ 0\\.005876645490419403\ \(0\)\
\-\ vertebral\\:\\ 0\\.005860998995515179\ \(0\)\
\-\ in\\:\\ 0\\.005842595911823291\ \(0\)\
\-\ system\\:\\ 0\\.005830987816985784\ \(0\)\
\-\ hours\\:\\ 0\\.005823565526185089\ \(0\)\
\-\ about\\:\\ 0\\.005708938485449309\ \(0\)\
\-\ images\\:\\ 0\\.005682023888905906\ \(0\)\
\-\ used\\:\\ 0\\.005681428348263365\ \(0\)\
\-\ cardiac\\:\\ 0\\.005640964979117799\ \(0\)\
\-\ and\\:\\ 0\\.005615532241213054\ \(0\)\
\-\ its\\:\\ 0\\.005588442709628494\ \(0\)\
\-\ occur\\:\\ 0\\.005556406635669911\ \(0\)\
\-\ throughout\\:\\ 0\\.00554375619809346\ \(0\)\
\-\ compression\\:\\ 0\\.00554375619809346\ \(0\)\
\-\ the\\:\\ 0\\.005510803376401027\ \(0\)\
\-\ above\\:\\ 0\\.005427969942162593\ \(0\)\
\-\ middle\\:\\ 0\\.005416220051373375\ \(0\)\
\-\ cortical\\:\\ 0\\.005398743241899154\ \(0\)\
\-\ venous\\:\\ 0\\.005375711643773187\ \(0\)\
\-\ then\\:\\ 0\\.005270306548391836\ \(0\)\
\-\ involving\\:\\ 0\\.005196546384754408\ \(0\)\
\-\ inflammatory\\:\\ 0\\.005135729539327598\ \(0\)\
\-\ side\\:\\ 0\\.005130756502190764\ \(0\)\
\-\ presentation\\:\\ 0\\.0051012142712150476\ \(0\)\
\-\ by\\:\\ 0\\.004931961536377382\ \(0\)\
\-\ bilaterally\\:\\ 0\\.004864307172485101\ \(0\)\
\-\ disease\\:\\ 0\\.00484137795915322\ \(0\)\
\-\ body\\:\\ 0\\.004809815793221983\ \(0\)\
\-\ often\\:\\ 0\\.004725257449774094\ \(0\)\
\-\ further\\:\\ 0\\.004709608564645161\ \(0\)\
\-\ past\\:\\ 0\\.0047057183222641834\ \(0\)\
\-\ adjacent\\:\\ 0\\.004682558482035125\ \(0\)\
\-\ while\\:\\ 0\\.004659704055203316\ \(0\)\
\-\ severe\\:\\ 0\\.004556862738415952\ \(0\)\
\-\ clinical\\:\\ 0\\.004556862738415952\ \(0\)\
\-\ some\\:\\ 0\\.004497276003235284\ \(0\)\
\-\ brain\\:\\ 0\\.00445641511837567\ \(0\)\
\-\ from\\:\\ 0\\.004389725175577858\ \(0\)\
\-\ primary\\:\\ 0\\.004387147769316631\ \(0\)\
\-\ loss\\:\\ 0\\.004298898045872512\ \(0\)\
\-\ not\\:\\ 0\\.004280134044166154\ \(0\)\
\-\ y\\.o\\:\\ 0\\.004274487751450087\ \(0\)\
\-\ when\\:\\ 0\\.004241475281830166\ \(0\)\
\-\ appearance\\:\\ 0\\.0042355399943408\ \(0\)\
\-\ abnormal\\:\\ 0\\.004223730052538841\ \(0\)\
\-\ region\\:\\ 0\\.004183017724851495\ \(0\)\
\-\ secondary\\:\\ 0\\.004140433217519597\ \(0\)\
\-\ a\\:\\ 0\\.004124088060505386\ \(0\)\
\-\ high\\:\\ 0\\.00405293944727351\ \(0\)\
\-\ distal\\:\\ 0\\.0040264793569255225\ \(0\)\
\-\ if\\:\\ 0\\.004018619469290529\ \(0\)\
\-\ lobe\\:\\ 0\\.003984965940942\ \(0\)\
\-\ due\\:\\ 0\\.003951953471322079\ \(0\)\
\-\ than\\:\\ 0\\.00388050061510966\ \(0\)\
\-\ who\\:\\ 0\\.003861297069569674\ \(0\)\
\-\ these\\:\\ 0\\.003854150246027452\ \(0\)\
\-\ prior\\:\\ 0\\.0038026217889122415\ \(0\)\
\-\ over\\:\\ 0\\.003770611074765966\ \(0\)\
\-\ to\\:\\ 0\\.0037007635047052534\ \(0\)\
\-\ upper\\:\\ 0\\.003573796369789806\ \(0\)\
\-\ into\\:\\ 0\\.00352396250946223\ \(0\)\
\-\ tissue\\:\\ 0\\.0035102620250478224\ \(0\)\
\-\ mri\\:\\ 0\\.0034025578074776772\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0034007267431203116\ \(0\)\
\-\ it\\:\\ 0\\.0033290266629688327\ \(0\)\
\-\ have\\:\\ 0\\.003206998402712464\ \(0\)\
\-\ lateral\\:\\ 0\\.0032004645504758234\ \(0\)\
\-\ but\\:\\ 0\\.0031585845771811743\ \(0\)\
\-\ after\\:\\ 0\\.0030641268676069363\ \(0\)\
\-\ female\\:\\ 0\\.00304464518448498\ \(0\)\
\-\ patient\\:\\ 0\\.0029691228108020377\ \(0\)\
\-\ is\\:\\ 0\\.002923522244634622\ \(0\)\
\-\ also\\:\\ 0\\.0029196180132931566\ \(0\)\
\-\ of\\:\\ 0\\.002826781995098506\ \(0\)\
\-\ within\\:\\ 0\\.0028251844166136595\ \(0\)\
\-\ has\\:\\ 0\\.0027811091343055076\ \(0\)\
\-\ which\\:\\ 0\\.0027645486780633424\ \(0\)\
\-\ that\\:\\ 0\\.0025580255260984805\ \(0\)\
\-\ for\\:\\ 0\\.002527237950234714\ \(0\)\
\-\ normal\\:\\ 0\\.0023216853632566743\ \(0\)\
\-\ ct\\:\\ 0\\.0020715834547522407\ \(0\)\
\-\ history\\:\\ 0\\.002045432474362363\ \(0\)\
\-\ \\.\\:\\ 0\\.0017226811277741693\ \(0\)\
\-\ this\\:\\ 0\\.0016657490698685146\ \(0\)\
\-\ right\\:\\ 0\\.0015626199464651934\ \(0\)\
\-\ old\\:\\ 0\\.0015163511210784307\ \(0\)\
\-\ on\\:\\ 0\\.0012545771444808112\ \(0\)\
\-\ with\\:\\ 0\\.00020278020119564945\ \(0\)\
